References

1. Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114(10):1764-1769.
2. Damm M, Temmel A, Welge-Lüssen A, et al. [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland].HNO. 2004;52(2):112-120.
3. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020.
4. Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020.
5. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020.
6. Moein ST, Hashemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020.
7. Lechner M, Chandrasekharan D, Jumani K, et al. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management. Rhinology. 2020.
8. Parma V, Ohla K, Veldhuizen MG, et al. More than just smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. medRxiv. 2020:2020.2005.2004.20090902.
9. Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature Medicine. 2020.
10. Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. Olfactory dysfunction predicts 5-year mortality in older adults.PLoS One. 2014;9(10):e107541.
11. Laudisio A, Navarini L, Margiotta DPE, et al. The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study. J Immunol Res.2019;2019:3128231.
12. Liu B, Luo Z, Pinto JM, et al. Relationship Between Poor Olfaction and Mortality Among Community-Dwelling Older Adults: A Cohort Study.Ann Intern Med. 2019;170(10):673-681.
13. Devanand DP, Lee S, Manly J, et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol.2015;78(3):401-411.
14. Philpott CM, Boak D. The impact of olfactory disorders in the United kingdom. Chem Senses. 2014;39(8):711-718.
15. Erskine SE, Philpott CM. An unmet need: Patients with smell and taste disorders. Clin Otolaryngol. 2020;45(2):197-203.
16. Erskine SE, Notley C, Wilson AM, Philpott CM. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions. J Asthma. 2015;52(6):600-605.
17. Erskine SE, Verkerk MM, Notley C, Williamson IG, Philpott CM. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study. Clin Otolaryngol. 2016;41(1):8-14.
18. Hickey G, Richards T, Sheehy J. Co-production from proposal to paper. Nature. 2018;562(7725):29-31.
19. Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord.2013;13(1):8.
20. Langstaff L, Pradhan N, Clark A, et al. Validation of the olfactory disorders questionnaire for English-speaking patients with olfactory disorders. Clin Otolaryngol. 2019;44(5):715-728.
21. Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1-30.
22. Philpott CM. Smell and taste disorders in the UK: first experience with a specialised small and taste outpatient clinic. Ann R Coll Surg Engl. 2014;96:156-159.
23. McNeill E, Ramakrishnan Y, Carrie S. Diagnosis and management of olfactory disorders: survey of UK-based consultants and literature review. J Laryngol Otol. 2007;121(8):713-720.